+12 Refractory Multiple Myeloma Ideas. Multiple myeloma is relatively rare and only represents around 1.8% of all. Web the increase in the number of therapeutic alternatives for both newly diagnosed and relapsed/refractory multiple myeloma (rrmm) patients has widened the clinical scenario, leading to a level of complexity that no algorithm has been able to cover up to date.
“relapsed myeloma” is previously treated myeloma that has progressed after prior therapy and requires new therapy [ 2 ]. Web most patients with relapsed/refractory multiple myeloma (rrmm) have been treated with drug combinations including a proteasome inhibitor (pi) and/or an immunomodulatory drug (imid). Multiple myeloma is a cancer that affects a type of white blood cell called a plasma cell, which helps your immune system.
